Skip to main content
Upcoming presentations/meetings
JP Morgan Healthcare Conference, San Fransisco
Redeye Commercialization in Life Science
Interim report for January - March 2025
Annual General Meeting of Moberg Pharma
Interim report for January - June 2025
Interim report for January - September 2025
Previous presentations/meetings
Interim report for January - September 2024
At the heart of Pharma, CPHI Global Conference in Milan
Teleconference regarding press release
Redeye Investor Forum Online
Interim report for January - June 2024
Bio International Convention, San Diego, June 3-6
Redeye Investor Forum Online
Annual General Meeting of Moberg Pharma
Interim report for January - March 2024
Bio Europe Spring, Barcelona, March 18-20
AAD Annual Meeting, San Diego, March 8-12
Swiss Nordic Bio 2024, Zurich, March 7
Interim report för January - September 2023
Redeye Investor Forum Online
Videointerview about launch plans and rights issue
Interim report for January - June 2023
Presentation of Moberg Pharma
Annual General Meeting of Moberg Pharma
Annual General Meeting of Moberg Pharma
Interim report for January - March 2023
AAD Annual Meeting, New Orleans
CEO Interview with Anna Ljung
Interim report for January - September 2022
Aktiespararnas digital Life Science Day
Interim report for January - June 2022
CEO Interview with Anna Ljung
CEO Interview with Anna Ljung
Interim report for January - March 2022
AAD Annual Meeting, Boston, MA, 25-29 March
SCF Life Science Corporate Finance Day, Stockholm
CEO Interview with Anna Ljung
Year-end report for the financial year 2021